Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
Gabriel G. Malouf(Centre National de la Recherche Scientifique), Nizar M. Tannir(The University of Texas MD Anderson Cancer Center), John N. Weinstein(The University of Texas MD Anderson Cancer Center), Denaha J. Doss, Liangwen Xiong(Spanish Oncology Genitourinary Group), Bin Tean Teh(Van Andel Institute), Erika J. Thompson(The University of Texas MD Anderson Cancer Center), Bernard Escudier(Institut Gustave Roussy), Éva Compérat(Vienna General Hospital), Jianjun Gao, Philippe Camparo(Centre Hospitalier Universitaire Amiens-Picardie), Xiaoping Su(The University of Texas MD Anderson Cancer Center), Vincent Molinié(Hôpital Saint Joseph), Willie Yu(Duke-NUS Medical School), Hui Yao(Wannan Medical College), Jérôme Couturier(Institut Curie), Christopher G. Wood(The University of Texas MD Anderson Cancer Center), David Khayat, Qiuming He(Spanish Oncology Genitourinary Group)
Cited by 141
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
|New England Journal of Medicine|2018|4.6k